Life Sciences/Biotech

Docs Introduce Insurance-Eligible Breakthrough For Treatment Of Addiction To Heroin, Painkillers

WEST BLOOMFIELD ? Medical Doctors at the Eagle Advancement Institute have introduced a new treatment for addicts of opioid-based substances like heroin and prescription pain killers. The treatment process, now being marketed as Clarity Intensive Outpatient Opioid Treatment, combines innovation in medical and psychological techniques to keep patients drug free. Eagle?s physicians are reporting successful

By |2014-12-05T00:00:00-05:00December 5th, 2014|Archive, Life Sciences/Biotech|

Karmanos Cancer Institute?s Researcher Awarded $1.8 Million Grant To Improve Access To Cancer Survivor Resources

DETROIT - Hayley S. Thompson, Ph. D., associate professor, Population Studies and Disparities Research Program at the Barbara Ann Karmanos Cancer Institute, and Department of Oncology, Wayne State University School of Medicine, has been awarded a $1.8 million grant from the Agency for Healthcare Research and Quality, which will be given over the next four

By |2014-11-28T00:00:00-05:00November 28th, 2014|Archive, Life Sciences/Biotech|

MichBio Career Center Posts 3 Life Sciences Job Openings

LANSING ? The MichBio Career Center has posted three life science jobs, including two high paying gigs in Ann Arbor. Biomedical Equipment Technician - work abroad CHSi Middle East - Baghdad, Iraq The MSSI in Iraq Program Manager establishes a clinically safe and professionally managed healthcare environment and provides primary health care as well as

By |2014-11-19T00:00:00-05:00November 19th, 2014|Archive, Life Sciences/Biotech|

ONL Therapeutics Awarded $1.37 Million SBIR Phase II Grant

ANN ARBOR - ONL Therapeutics, a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, Wednesday announced it has been awarded a $1.37 million Small Business Innovation Research Phase II contract from the National Eye Institute to advance development of ONL101, the company?s lead therapeutic candidate. ONL101 is a first-in-class

By |2014-11-12T00:00:00-05:00November 12th, 2014|Archive, Life Sciences/Biotech|

Healthy Michigan Enrollees Almost Hit 450,000

LANSING - The state is just 51 persons short of 450,000 people having signed up for the Healthy Michigan Medicaid expanded enrollment, meaning the state could actually hit the total number of people it had ever expected to enroll by early December. On Monday, the Department of Community Health said 449,949 people had enrolled in

By |2014-11-10T00:00:00-05:00November 10th, 2014|Archive, Life Sciences/Biotech|

Sanders Added to Delphinus As Vice President of Engineering

PLYMOUTH TOWNSHIP - Delphinus Medical Technologies, the first company to design and manufacture a whole breast ultrasound system that incorporates circular transducer technology, announced last month that Chris Sanders has joined the executive team as vice president of engineering. He comes to Delphinus with over 20 years of extensive global innovation and manufacturing expertise in

By |2014-11-03T00:00:00-05:00November 3rd, 2014|Archive, Life Sciences/Biotech|

Tetra Discovery Partners Lands More Private Financing

GRAND RAPIDS - Tetra Discovery Partners, a drug discovery company developing a portfolio of innovative drugs for psychiatric, neurological and inflammatory diseases, announced additional private financing. The company has received additional financing from previous seed investor Grand Angels, as well as an investment by Johnson & Johnson Development Corporation. Tetra additionally announced the formation of

By |2014-11-03T00:00:00-05:00November 3rd, 2014|Archive, Life Sciences/Biotech|

Vestaron Closes $4 Million Series C Round

KALAMAZOO - Vestaron Corporation, a company that designs environmentally friendly insecticides, announced the final close of its Series C Financing. Anterra Capital, based in the Netherlands, added $4 Million to the $10 Million previously announced to bring total funding to $14 Million. Anterra Capital is jointly funded by Moonray Investors, the proprietary investment arm of

By |2014-11-03T00:00:00-05:00November 3rd, 2014|Archive, Life Sciences/Biotech|